Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Payables (2016 - 2025)

Healthy Extracts filings provide 11 years of Payables readings, the most recent being $219826.0 for Q4 2025.

  • On a quarterly basis, Payables rose 302.06% to $219826.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $219826.0, a 302.06% increase, with the full-year FY2025 number at $219826.0, up 302.06% from a year prior.
  • Payables hit $219826.0 in Q4 2025 for Healthy Extracts, down from $231963.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $887908.0 in Q3 2021 to a low of $54675.0 in Q4 2024.
  • Median Payables over the past 5 years was $402390.0 (2021), compared with a mean of $412708.8.
  • Biggest five-year swings in Payables: soared 1431.67% in 2021 and later plummeted 88.56% in 2024.
  • Healthy Extracts' Payables stood at $209017.0 in 2021, then skyrocketed by 95.49% to $408600.0 in 2022, then rose by 16.97% to $477935.0 in 2023, then plummeted by 88.56% to $54675.0 in 2024, then surged by 302.06% to $219826.0 in 2025.
  • The last three reported values for Payables were $219826.0 (Q4 2025), $231963.0 (Q3 2025), and $270152.0 (Q2 2025) per Business Quant data.